Correlation Between Vivos Therapeutics and Cooper Companies,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Cooper Companies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Cooper Companies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and The Cooper Companies,, you can compare the effects of market volatilities on Vivos Therapeutics and Cooper Companies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Cooper Companies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Cooper Companies,.

Diversification Opportunities for Vivos Therapeutics and Cooper Companies,

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vivos and Cooper is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and The Cooper Companies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cooper Companies, and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Cooper Companies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cooper Companies, has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Cooper Companies, go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Cooper Companies,

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 4.81 times more return on investment than Cooper Companies,. However, Vivos Therapeutics is 4.81 times more volatile than The Cooper Companies,. It trades about 0.13 of its potential returns per unit of risk. The Cooper Companies, is currently generating about 0.13 per unit of risk. If you would invest  512.00  in Vivos Therapeutics on October 24, 2024 and sell it today you would earn a total of  62.00  from holding Vivos Therapeutics or generate 12.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vivos Therapeutics  vs.  The Cooper Companies,

 Performance 
       Timeline  
Vivos Therapeutics 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Cooper Companies, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Cooper Companies, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Vivos Therapeutics and Cooper Companies, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vivos Therapeutics and Cooper Companies,

The main advantage of trading using opposite Vivos Therapeutics and Cooper Companies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Cooper Companies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cooper Companies, will offset losses from the drop in Cooper Companies,'s long position.
The idea behind Vivos Therapeutics and The Cooper Companies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios